RTW Investments, LP
The RTW Podcast
We’re witnessing a healthcare revolution, as medical and science innovations transform the lives of millions. Join as we speak to bright scientific minds, inspiring company founders and healthcare champions that are driving this exciting period of scientific discovery. Subscribe to catch each episode as it goes live. The content of this podcast does not constitute investment advice, an offer to provide investment advisory services, or an offer to sell or solicitation of an offer to buy an interest in any investment fund.
Be sure to visit the podcast's website and support the creator: rss.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Surviving Stage IV Cancer: The Power of Patient Peer Navigators 19.10.2026 24:45
At 49, Karen Peterson was diagnosed with triple-negative breast cancer. Two years later it was stage IV, with a prognosis measured in months. Karen tells Stephanie Sirota how biomarker testing and a Phase 1 immunotherapy trial saved her life, why she walked out on her original oncologist, and what underrepresentation in clinical trials looks like up close. She also explains how Karen's Club, a New...
Biotech's Early Innings: The Signals Investors Should Watch For 13.10.2026 28:08
Episode Description Is there still time for investors to join the biotech rally, or have they already missed it? Rod Wong says there is still plenty of opportunity and sits down with Stephanie Sirota to make the case. They start by contrasting high-profile concerns about AI’s risks with Rod’s more measured view: manage the downside, and position early to capture the benefits. He then explains why...
The 3x Survivor: CEO of Her Own Body: Amanda Rice on Patient Self-Advocacy and the Fight for Fertility Preservation Coverage 22.09.2026 23:36
A cancer diagnosis in your early 30s. A doctor who says chemotherapy could leave you infertile. An insurer who says you don't qualify for fertility benefits because you "aren't infertile yet." Amanda Rice lived that call and built The Chick Mission in response: a nonprofit that has funded egg-freezing cycles for nearly 900 women and helped pass fertility preservation coverage into law in 22 states...
Innovation is the Best Medicine 10.09.2026 20:15
RTW Podcast Episode 302: Innovation is the Best Medicine: Rod Wong on Driving Innovation and Fixing the Affordability Crisis Episode Description American medical care rests on two pillars: innovation and affordability. Get either one wrong and patients pay the price. RTW's Rod Wong joins Stephanie Sirota to unpack both. On innovation, they trace the “Innovation Treadmill,” the cycle that forces dr...
Redefining the Weight Loss Revolution Beyond GLP1s: Influential Voices in the New Food Economy 19.08.2026 25:20
Americans spend $1.4 trillion a year on food, and a growing share of that spending is decided in the grocery aisle by people holding a phone. Hunter Stoler, the certified health coach behind Health with Hunter, joins RTW's Stephanie Sirota to discuss what nearly two million followers are putting in their carts and why the largest retailers are paying attention. From losing 50 pounds and keeping it...
Psilocybin on the Verge: Treating Depression at Compass Pathways 20.07.2026 24:02
Treatment-resistant depression affects four million Americans, and until now, patients have had almost no options. Dr. Steve Levine of Compass Pathways joins RTW's Stephanie Sirota to discuss COMP360, a psilocybin-based therapy for treatment-resistant depression. From the science behind rapid and durable response, to the regulatory path, reimbursement infrastructure, and what's next for PTSD, this...
Psilocybin: Counterculture to Cutting-Edge Psychiatry 22.06.2026 24:52
Are psychedelics poised to transform mental health treatment? Connor Williams joins Stephanie Sirota for a deep dive into psilocybin, the science behind its effects on the brain, and its potential in treatment-resistant depression, PTSD, and other serious conditions. As clinical trials advance and FDA pathways take shape, psychedelics have moved from counterculture to clinic, raising critical ques...
ASCO: The Biggest Event in Oncology 28.05.2026 24:59
For decades, some cancers were a near-certain death sentence. Now, a new generation of cancer drugs—many coming from biotech, not big pharma—is changing that. RTW’s Chris Liu discusses ASCO 2026, and breakthroughs in pancreatic cancer, lung cancer, and other hard-to-treat tumors. What's driving the progress, why is it happening now, and what does it mean for the future of cancer care? PODCAST TEAM...
Women's Health: An Investing Whitespace 27.04.2026 20:06
Menopause, perimenopause, and hormone replacement therapy (HRT) are reshaping the conversation around women’s health and longevity. OB/GYN Dr. Stephanie Lam explains the science, symptoms, and why women’s healthcare may represent a major investing whitespace. PODCAST TEAM Producer & Director: Devon Leaver Editor: Dominique Guerra Production Coordinator: Ying Yu Lin Production support: Annabell...
Gene Editing: From CRISPR to Curative Medicine 30.03.2026 24:20
What if you could fix disease by rewriting DNA? From CRISPR to next-gen gene editing, Stephanie Sirota and Beam Therapeutics CEO John Evans break down base editing, prime editing, and the path to one-time cures. PODCAST TEAM Producer & Director: Devon Leaver Editor: Dominique Guerra Production Coordinator: Ying Yu Lin Production support: Annabelle Chan Executive Editorial Advisor: Stephanie Si...
Biotech’s Next Era: Innovation and Commercialization 12.01.2026 24:57
Rod Wong joins Stephanie Sirota to trace biotech's evolution. What forces built today’s innovation landscape, and what might the next decade reveal? PODCAST TEAM Producer & Director: Devon Leaver Editor: Dominique Guerra Production Coordinator: YingYu Lin Production Support: Annabelle Chan Theme music: Ganymede by Yehezkel Raz Additional music: APM Music Featuring: Rod Wong, Managing Partner a...
The Split Vote: UroGen and the FDA 01.12.2025 23:56
When an FDA panel held her company’s future in the balance, UroGen Pharma CEO Liz Barrett refused to fold, even with the odds stacked, a plunging stock, and one vote deciding it all. PODCAST TEAM Producer and Director: Devon Leaver Editor: Dominique Guerra Production Coordinator: YingYu Lin Production Support: Annabelle Chan Story Consultants: Partner & Research Analyst Tony Nguyen, and Chief...
14 Months to Treatment: Breaking Records in Rare Disease Therapy 06.10.2025 22:21
From a Thanksgiving night emergency to one of the fastest gene therapies ever deployed, this is the story of a family’s relentless pursuit to help their daughter, and how RTW Foundation made it possible. This episode was recorded on June 11, 2025, and the clinical trial details discussed may have changed; please see ellysteam.org for the most current information on Elly’s case. PODCAST TEAM Produc...
Losing Sleep and Lives: Matthew Walker on the Global Sleep Epidemic 15.09.2025 24:52
Lack of sleep can be deadly and costly. Matthew Walker, author of NYT bestseller Why We Sleep and Stephanie Sirota explore the science of sleep, how not sleeping can hurt our health and economy, and the global sleep epidemic. PODCAST TEAM Producer: Devon Leaver Editor: Dominique Guerra Featuring: Dr. Matthew Walker PhD, Author of Why We Sleep: Unlocking the Power of Sleep and Dreams, moderated by...
From drop to double: Akero’s surging stock 14.07.2025 13:47
When Akero’s stock dropped after a trial setback, why did RTW double down that same day? CEO Andrew Cheng joins RTW’s Rod Wong to share how he navigated the biotech storm, why he believed in efruxifermin (EFX,) and what’s next for liver disease treatment. PODCAST TEAM Producer: Devon Leaver Editor: Dominique Guerra Production Coordinator: YingYu Lin Featuring: Andrew Cheng, CEO of Akero Therapeuti...
Ditching Delay: GH001’s Instant Impact on Depression 05.05.2025 22:02
Connor Williams was shocked when the data came back for GH001. What could this mean for the future of treatment-resistant depression? Listen to his exclusive interview with Dr. Valcheva, the CEO of GH Research, to find out. PODCAST TEAM Producer: Devon Leaver Editor: Dominique Guerra Featuring: Dr. Velichka (Villy) Valcheva MD, CEO of GH Research moderated by Connor Williams, Senior Research Analy...
Changing Minds: Psychedelics as Legitimate Medicine 07.04.2025 23:22
If you’re dismissing psychedelics in pharma, think again. Stephanie Sirota and Connor Williams discuss overcoming stigma and regulatory challenges, and the results of a recent clinical trial that could signal a new era for mental health care. PODCAST TEAM Producer: Devon Leaver Editor: Dominique Guerra Featuring: Connor Williams, Senior Researcher at RTW Investments, moderated by Stephanie A. Siro...
Inside the clinic: GLP-1s with Dr. Rekha B. Kumar 22.01.2025 20:59
Dr. Rekha Kumar, Chief Medical Officer at Found, and Stephanie Sirota explore Rekha’s rise from academia, and her passion for obesity medicine. As new weight management therapies emerge, Rekha emphasizes the importance of lifestyle changes to maximize their potential. PODCAST TEAM Producer: Devon Leaver Editor: Dominique Guerra Featuring: Dr. Rekha B. Kumar, moderated by Stephanie Sirota. Don't fo...
The $1 trillion GLP-1 revolution with Rod Wong 06.01.2025 20:42
Rod Wong and Stephanie Sirota delve into the transformative potential of GLP-1 drugs, focusing on their impact on obesity and related diseases. Rod shares his insights into the next generation of obesity therapies and the opportunities they present for innovation and investment in the biotech sector. PODCAST TEAM Producer: Devon Leaver Editor: Dominique Guerra Featuring: Rod Wong, moderated by Ste...
Revolutionizing RNA therapeutics - Avidity Biosciences 12.08.2024 22:10
Sarah Boyce from Avidity Biosciences and Piratip Pratumsuwan from RTW Investments explore the strategic decisions and innovations that have driven Avidity's success. They cover her approach to overcoming the challenges of scaling a biotech company, the impact of Avidity’s groundbreaking work on treating rare genetic disorders, and Sarah’s vision for the future of RNA-based therapies. PODCAST TEAM...
The power of partnership – Prometheus Biosciences 01.12.2023 44:43
Mark McKenna from Prometheus Biosciences and Josh Kennedy-Smith from RTW Investments tell us about the white-knuckle ride that is building a pharmaceutical start-up, their passion for providing better care solutions for patients, the recent deal with Merck and the power of a strong partnership with your investor. Host: Josh Baldwin, RTW Investments Featuring: Mark McKenna, CEO of Prometheus Biosci...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.